AI Artificial Intelligence31 Aug 2018 18:03
w are clearly going to capture this space. David has a 30-year history of successfully building life sciences businesses in Europe and the United States, including Biocompatibles plc where he initiated the ophthalmology and cardiology businesses in a period that saw their sales grow from zero to over £40m pa, business development for Carl Zeiss in which he reinvigorated their mature ophthalmology capital equipment business to grow more than 15% pa resulting in sales in excess of £150m. In addition, the foundation of California based Tenaxis Medical, where having raised $22m from investors David led the company through product development, built a strong operating team, achieved regulatory approvals and secured the company's first sales. Tenaxis Medical was sold for $178m in 2014. Trevor Brown, CEO of Flying Brands, commented: "I am delighted to welcome David to Flying Brands. I believe that the Company will benefit greatly from the breadth of his experience, not only from his proven ability to actualize strategic vision into strongly growing revenue, but also from applying his deep knowledge of the US medical market to our growing Artificial Intelligence product portfolio."